摘要
目的:研究水飞蓟宾治疗非酒精性脂肪肝的临床效果。方法:将非酒精性脂肪肝患者77例分为两组,一组为治疗组,另一组为对照组;治疗组应用水飞蓟宾胶囊35mg/片,2片/次,3次/d,口服;对照组则应用还原型谷胱甘肽片0.1g/片,2片/次,3次/d。结果:治疗组在改善肝功能及降低血清甘油三酯方面均比对照组有明显的差异,具有统计学意义。结论:水飞蓟宾治疗非酒精性脂肪肝有较好的临床效果。
Objectiv： To observe the effect of silibinin capsules on treating non-alcoholic fatty liver disease. Methods： 77 patients with non-alcoholic fatty liver disease were divided into two groups. Patients in the treatment group took orally two tablets of silibinin capsules, 35mg/tablet, three time a day; while patients in the control group took two pieces of reduced glutathione tablets, 0. 1g / tablet, three time a day. Results： The treatment group had made more obvious effect than the control group in improving liver functions and TG, which was of statistical difference. Conclusion： Silibinin capsule has obtained good effect in treating patients with non-alcoholic fatty liver disease.
出处
《华夏医学》
CAS
2013年第1期73-75,共3页
Acta Medicinae Sinica
关键词
非酒精性脂肪肝
水飞蓟宾胶囊
还原型谷胱甘肽片
non-alcoholic fatty liver disease
silibinin eapsule
reduced glutathiore tablet
